| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; 1:250; loading ...; fig 5b
| Silva M, Nandi G, Tentarelli S, Gurrell I, Jamier T, Lucente D, et al. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons. Nat Commun. 2020;11:3258 pubmed publisher |
- western blot; human; loading ...; fig 5
| Wang J, Qiao L, Hou Z, Luo G. TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection. J Virol. 2017;91: pubmed publisher |
- immunocytochemistry; human; fig 2
| Alford J, Marongiu M, Watkins G, Anderson E. Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner. PLoS ONE. 2016;11:e0158941 pubmed publisher |
- western blot; human; 1:250; fig 1
| Angeloni N, McMahon K, Swaminathan S, Plebanek M, Osman I, Volpert O, et al. Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1. Sci Rep. 2016;6:22915 pubmed publisher |
- immunoprecipitation; human; loading ...; fig 10a
- western blot; human; loading ...; fig 10a
| Le Q, Blanchet M, Seidah N, Labonté P. Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. J Biol Chem. 2015;290:23385-400 pubmed publisher |
- immunocytochemistry; human; 5 ug/ml; loading ...; fig 5b
| Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N, et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci U S A. 2014;111:E1264-73 pubmed publisher |
| Prentoe J, Serre S, Ramírez S, Nicosia A, Gottwein J, Bukh J. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J Virol. 2014;88:1725-39 pubmed publisher |
| Wu C, Li Z, Feng G, Wang L, Xie J, Jin Y, et al. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway. Bioengineered. 2021;12:8378-8395 pubmed publisher |
| Zhao Y, Jin L, Zhang X. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1. Aging (Albany NY). 2021;13:18498-18514 pubmed publisher |
| McKnight K, Xie L, González López O, Rivera Serrano E, Chen X, Lemon S. Protein composition of the hepatitis A virus quasi-envelope. Proc Natl Acad Sci U S A. 2017;114:6587-6592 pubmed publisher |
| Villarroya Beltri C, Baixauli F, Mittelbrunn M, Fernandez Delgado I, Torralba D, Moreno Gonzalo O, et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun. 2016;7:13588 pubmed publisher |
| Li Q, Sodroski C, Lowey B, Schweitzer C, Cha H, Zhang F, et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:7620-5 pubmed publisher |
| Bukong T, Momen Heravi F, Kodys K, Bala S, Szabo G. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog. 2014;10:e1004424 pubmed publisher |
| Murakami Y, Fukasawa M, Kaneko Y, Suzuki T, Wakita T, Fukazawa H. Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. Microbes Infect. 2013;15:45-55 pubmed publisher |
